Delta 9 Cannabis EBITDA
Was ist das EBITDA von Delta 9 Cannabis?
EBITDA von Delta 9 Cannabis Inc. ist -CAD$11.41
Was ist die Definition von EBITDA?
Das EBITDA ist das Ergebnis eines Unternehmens vor Zinsen, Steuern, Abschreibungen und Amortisationen und ist eine Buchhaltungsgröße, die anhand des Nettoergebnisses eines Unternehmens berechnet wird, bevor Zinsaufwendungen, Steuern, Abschreibungen und Amortisationen abgezogen werden, um die derzeitige operative Ertragskraft eines Unternehmens zu ermitteln.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA von Unternehmen in Health Care Sektor auf TSX im Vergleich zu Delta 9 Cannabis
Was macht Delta 9 Cannabis?
Delta 9 Cannabis Inc. operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc., engages in the cultivation, processing, extraction, wholesale distribution, retail, and sale of medical and recreational cannabis and related merchandise and devices. As of August 24, 2021, it owned and operated 13 retail stores under the Delta 9 brand name. Delta 9 Cannabis Inc. was founded in 2012 and is headquartered in Winnipeg, Canada.
Unternehmen mit ebitda ähnlich Delta 9 Cannabis
- Experience Co hat EBITDA von -AUD$11.47
- Heidelberg Pharma AG hat EBITDA von -€11.45
- Guru Online () hat EBITDA von -HKD$11.45
- The Real Brokerage Inc hat EBITDA von -$11.45
- Phunware Inc hat EBITDA von -$11.44
- Marin Software Inc hat EBITDA von -$11.42
- Delta 9 Cannabis hat EBITDA von -CAD$11.41
- Skye Bioscience hat EBITDA von -$11.38
- MusclePharm hat EBITDA von -$11.38
- InfraStrata Plc hat EBITDA von -£11.38
- Camurus AB (publ) hat EBITDA von -kr11.38
- Orbite Technologies hat EBITDA von -CAD$11.38
- NorZinc hat EBITDA von -CAD$11.37